[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
FP Polack, SJ Thomas, N Kitchin, J Absalon… - repositorioacademico.upc.edu.pe
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Page 1 The new england journal
of medicine n engl j med 383;27 nejm.org December 31, 2020 2603 established in 1812 …
of medicine n engl j med 383;27 nejm.org December 31, 2020 2603 established in 1812 …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
FP Polack, SJ Thomas, N Kitchin, J Absalon… - The New England …, 2020 - europepmc.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
FP Polack, SJ Thomas, N Kitchin, J Absalon… - 2020 - observatoriovacunascovid19.unam …
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
FP Polack, SJ Thomas, N Kitchin, J Absalon… - New England Journal …, 2020 - cir.nii.ac.jp
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
C4591001 Clinical Trial Group - New England Journal of …, 2020 - pure.johnshopkins.edu
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of …
and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of …
[PDF][PDF] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
FP Polack - 2020 - square.umin.ac.jp
[方法] 複数の国で, 観察者には治療法が分からないようにした, プラセボとの比較における有効性を
明らかにする試験において, 我々は 16 歳以上の人たちに 1: 1 の割合でプラセボか BNT162b2 …
明らかにする試験において, 我々は 16 歳以上の人たちに 1: 1 の割合でプラセボか BNT162b2 …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
FP Polack, SJ Thomas, N Kitchin… - The New England …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
FP Polack, SJ Thomas, N Kitchin, JL Perez, GP Marc… - 2021 - arca.fiocruz.br
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting
coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide …
coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide …
[引用][C] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
F Polack, S Thomas, N Kitchin… - NEW ENGLAND …, 2020 - avesis.hacettepe.edu.tr
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | AVESİS Hacettepe
Üniversitesi Akademik Veri Yönetim Sistemi Araştırmacı Girişi English Detaylı Arama Ana …
Üniversitesi Akademik Veri Yönetim Sistemi Araştırmacı Girişi English Detaylı Arama Ana …